Two recent studies looked at ways ophthalmologists might be able to screen for disease more effectively. In the first study, researchers from Washington University in St. Louis and Blue Sky Neurology of Denver investigated whether or not retinal changes might allow clinicians to catch preclinical Alzheimer’s disease. “We were interested in looking at the retina because, in more advanced neurodegenerative diseases, there’s been some evidence of retinal thinning in the past, both in the neuro and vascular components,” said study co-author Raj Apte, MD, PhD. The other study that sought to learn more about screening methods evaluated several published studies of 11 artificial intelligence, deep-learning-based diabetic retinopathy screening algorithms to determine the algorithms’ accuracy. Find out more about these studies in this feature from Review of Ophthalmology. Read More.